These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29652176)

  • 21. Self-reported use of evidence-based medicine and smoking cessation 6 - 9 months after acute coronary syndrome: a single-centre perspective.
    Griffiths B; Lesosky M; Ntsekhe M
    S Afr Med J; 2014 Jun; 104(7):483-7. PubMed ID: 25214049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Medication Management and Medication Adherence for Chronic Conditions.
    Brummel A; Carlson AM
    J Manag Care Spec Pharm; 2016 Jan; 22(1):56-62. PubMed ID: 27015052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence-based use of medications in patients with coronary artery disease in a rural Australian community.
    Granmyr J; Ball P; Curran S; Wang L
    Aust J Rural Health; 2007 Aug; 15(4):241-6. PubMed ID: 17617087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of use of antiplatelet drugs, beta blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in older patients with coronary artery disease in an academic nursing home.
    Joseph J; Koka M; Aronow WS
    J Am Med Dir Assoc; 2008 Feb; 9(2):124-7. PubMed ID: 18261706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [SECONDARY PREVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME HOSPITALIZED IN INTERNAL MEDICINE DEPARTMENTS].
    Yahia DH; Pereg D; Lishner M; Elis A
    Harefuah; 2015 May; 154(5):299-302, 339-40. PubMed ID: 26168639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure.
    Joynt KE; Gattis WA; Hasselblad V; Fuzaylov SY; Serebruany VL; Gurbel PA; Gaulden LH; Felker GM; Whellan DJ; O'Connor CM
    Am J Cardiol; 2004 Mar; 93(6):783-5. PubMed ID: 15019895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.
    Maddox TM; Ho PM; Roe M; Dai D; Tsai TT; Rumsfeld JS
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):632-41. PubMed ID: 20923997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospital revascularisation capability and quality of care after an acute coronary syndrome in Switzerland.
    Welker J; Auer R; Gencer B; Muller O; Cornuz J; Matter CM; Mach F; Windecker S; Rodondi N; Nanchen D
    Swiss Med Wkly; 2016; 146():w14275. PubMed ID: 26859223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery.
    Looi KL; Chow KL; Looi JL; Lee M; Halliday S; White H; Ellis C
    N Z Med J; 2011 Sep; 124(1343):18-27. PubMed ID: 21964009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
    McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
    JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sudden cardiac death and the role of medical therapy.
    Arshad A; Mandava A; Kamath G; Musat D
    Prog Cardiovasc Dis; 2008; 50(6):420-38. PubMed ID: 18474285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and correlates of cardiovascular medication use among nursing home residents with ischemic heart disease: results from the SHELTER study.
    Foebel AD; Liperoti R; Gambassi G; Gindin J; Ben Israel J; Bernabei R; Onder G
    J Am Med Dir Assoc; 2014 Jun; 15(6):410-5. PubMed ID: 24559641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mental Disorders, Substance Use Disorders, and Psychotropic Medication Use Among Sudden-Death Victims.
    Ford J; Bushnell G; Griffith AM; Joodi G; Ashoka A; Patel N; Husain M; Pursell IW; Sears SF; Mounsey JP; Simpson RJ
    Psychiatr Serv; 2021 Apr; 72(4):378-383. PubMed ID: 33593102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in prevalence of and prescribing for ischaemic heart disease in Ireland 1990-2002.
    Bennett K; Johnson H; Dack P; Shelley E; Feely J
    Ir J Med Sci; 2005; 174(3):4-8. PubMed ID: 16285330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimated incidence and risk factors of sudden unexpected death.
    Lewis ME; Lin FC; Nanavati P; Mehta N; Mounsey L; Nwosu A; Pursell I; Chung EH; Mounsey JP; Simpson RJ
    Open Heart; 2016; 3(1):e000321. PubMed ID: 27042316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables.
    Feher G; Koltai K; Papp E; Alkonyi B; Solyom A; Kenyeres P; Kesmarky G; Czopf L; Toth K
    Drugs Aging; 2006; 23(7):559-67. PubMed ID: 16930084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival prospects after acute myocardial infarction in the UK: a matched cohort study 1987-2011.
    Gitsels LA; Kulinskaya E; Steel N
    BMJ Open; 2017 Jan; 7(1):e013570. PubMed ID: 28119386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation of Household Income to Incidence of Sudden Unexpected Death in Wake County, North Carolina.
    Mounsey LA; Lin FC; Pursell I; Joodi G; Lewis ME; Nwosu A; Hodonsky C; Simpson RJ; Mounsey JP
    Am J Cardiol; 2017 Apr; 119(7):1030-1035. PubMed ID: 28187864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of care for secondary prevention for patients with coronary heart disease: results of the Hastening the Effective Application of Research through Technology (HEART) trial.
    Goff DC; Gu L; Cantley LK; Sheedy DJ; Cohen SJ
    Am Heart J; 2003 Dec; 146(6):1045-51. PubMed ID: 14660997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.